This extended 10 ul combats contamination by keeping your pipettor out of 1.5 ul and 2.0 ul tubes. Utilizes MicroPoint design and 2 ul reference mark.
...noPrep LBP Processor is a primary component of an ..., accessioning, processing, sampling, and slide pr...-art data management. The MonoPrep LBP Processor p...cell layers from a broad range of cytology specime...
...rosol Resistant Tips offer a safe alternative to u... designed for applications such as PCR(a), pipetti...ddition, ART Tips are excellent for tissue culture...dies. ART Tips prevent aerosol contaminants and li...
Packed conveniently in plastic-wrapped racks of 96 tips, Sterilized Diamond- Tips are ready to useno need to autoclave. Sterilized Diamond Tips are irradiated by gamma-rays for more efficient sterili
Medicine Products:(Date:12/3/2008)...Health insurance premiums have slowed to less than...her costs, increased utilization and waste in the ...lth cost increases, a new report released today fi...rs (PwC) on behalf of America,s Health Insurance P...e Costs 2008" examines the causes of rising health...
(Date:12/3/2008)...edical transcription service provider MedQuist Inc...e allegations under the False Claims Act that it o...Department announced today. From 1998 onward, Med...everal federal government clients, including the D... of Defense (DOD) and the Public Health Service (P...
(Date:12/3/2008)...yet, experts say, , , WEDNESDAY, Dec....chniques will help doctors diagnose and stage brea...dard mammography for the detection of breast cance...g (BSGI) and positron emission mammography (PEM) -... cells. The tracer used in BSGI is positively char...
(Date:12/3/2008)...g free shipping to the end of the year. , ...the remainder of the year standard shipping for al... UK mainland addresses, excluding the highlands an...special voucher code SHIP4FREE on the Hyperdrug.co...ays "Hyperdrug intends to give practical help...
Breaking Medicine News(10 mins):Health News:New Report Shows Slower Premium Growth, But Increasing Pressure to Address Waste in Health Care System 2Health News:New Report Shows Slower Premium Growth, But Increasing Pressure to Address Waste in Health Care System 3Health News:New Jersey-Based MedQuist Pays U.S. $6.6 Million to Resolve False Claims Act Allegations 2Health News:Latest Breast Imaging Techniques Offer New Views 2Health News:Latest Breast Imaging Techniques Offer New Views 3Health News:Beating the Credit Crunch with Hyperdrug.co.uk 2(Date:11/30/2008)...re-USNewswire/ -- Abnormalities in auditory and la...h autism spectrum disorder by using magnetoencepha...ay at the annual meeting of the Radiological Socie... we can record the tiny magnetic fields associated...erts, Ph.D., vice chair of research in the Departm...
(Date:11/28/2008)...Newswire-FirstCall/ -- Eli Lilly and Company,(NYS... Application (sNDA) from,the U.S. Food and Drug A...l),for the management of chronic pain. Lilly plan...f 2009, adding data from a recently completed posi...knee. , The decision does not affect duloxe...
(Date:11/26/2008)... Children whose eyes ar...y increased risk of developing mental illness by e...linic study published this month in Pediatrics , t...iatrics. , , The retrospective study examin...smus (misaligned eyes) and compared them with reco...
(Date:11/26/2008)...jects , , FRANKLIN, Mass., Nov. 26 /PRNewsw...oard: PLCSF) announced today that it has received ...ration (FDA) for its U.S. pivotal trial to study t...m(TM) and associated therapy in the prevention of...e FDA also approved PLC,s request to expand their ...
Breaking Medicine Technology:Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Eye Divergence in Children Triples Risk of Mental Illness 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit of Use Compounding Kits 1946 1CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit of Use Compounding Kits 1946 2CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit of Use Compounding Kits 1946 3People With Chronic Conditions Experience Additional Benefits of Cost Savings by Wearing a Medical ID 1944 1People With Chronic Conditions Experience Additional Benefits of Cost Savings by Wearing a Medical ID 1944 2People With Chronic Conditions Experience Additional Benefits of Cost Savings by Wearing a Medical ID 1944 3People With Chronic Conditions Experience Additional Benefits of Cost Savings by Wearing a Medical ID 1944 4Yves Lionel Assant is New Chairman of Gerresheimers Supervisory Board 801 1Highlights of Economic and Business Growth in the Tampa Bay Region 800 1Highlights of Economic and Business Growth in the Tampa Bay Region 800 2Highlights of Economic and Business Growth in the Tampa Bay Region 800 3Highlights of Economic and Business Growth in the Tampa Bay Region 800 4... BROOMFIELD, Colo., June 11, 2007 /PRNewswire/ --...n-label extension of its Phase,IIb clinical trial ...t the Alzheimer,s Association,s International Conf...C. Consistent with the,findings of earlier clinica... safe and to significantly improve the memory and,...
... BRANFORD, Conn.--(BUSINESS WIRE)--Jun 11, 2007 - ...d that data from previous,Phase 1 clinical studies...reatment of insomnia, were presented today at the ...sional Sleep Societies,(APSS) in Minneapolis, Minn...n chronic insomnia patients are currently being,co...
Other Medicine Technology:Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 2Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 3Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 4Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 2Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 3Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 4